By Professor Don Edward Smith

Books

Smith DE, 1999, Protease inhibitor-sparing therapies: possible applications and suitability., Original

Book Chapters

Ramacciotti TP; Smith DE; Emery S; Kelleher AD; Cooper DA, 2005, 'Therapeutic vaccination in PHI', in Jenssen H; Jager H (ed.), Primary HIV Infection ? Pathology, Diagnosis, Management, Thieme, Stuttgart, pp. 48 - 63

Smith DE; Whittaker B; Crowe S; Hoy JF; French MA; Clezy KR; Beveridge A, 1997, 'Antiretroviral therapy for HIV infection: principles of use.', in Antiretroviral therapy for HIV infection: principles of use., edn. Original, ANCARD, Dept of Health and Human Services, Canberra, Australia, pp. 1 - 58

Journal articles

Walmsley S; Smith DE; Górgolas M; Cahn PE; Lutz T; Lacombe K; Kumar PN; Wynne B; Grove R; Bontempo G; Moodley R; Okoli C; Kisare M; Jones B; Clark A; Ait-Khaled M, 2024, 'Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.', AIDS Res Ther, 21, pp. 17, http://dx.doi.org/10.1186/s12981-024-00604-9

Dharan NJ; Jin F; Vaccher S; Bavinton B; Yeung B; Guy R; Carr A; Zablotska I; Amin J; Read P; Templeton DJ; Ooi C; Martin SJ; Ryder N; Smith DE; McNulty A; Brown K; Price K; Holden J; Grulich AE, 2023, 'Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)', Clinical Infectious Diseases, 76, pp. E622 - E628, http://dx.doi.org/10.1093/cid/ciac660

Batterham RL; Espinosa N; Katlama C; McKellar M; Scholten S; Smith DE; Ait-Khaled M; George N; Wright J; Gordon LA; Moodley R; Wynne B; van Wyk J, 2023, 'Cardiometabolic Parameters 3 Years After Switch to Dolutegravir/Lamivudine vs Maintenance of Tenofovir Alafenamide-Based Regimens.', Open Forum Infect Dis, 10, pp. ofad359, http://dx.doi.org/10.1093/ofid/ofad359

Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R, 2021, 'Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study', The Lancet HIV, 8, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(21)00074-6

Dharan NJ; Yeh P; Bloch M; Yeung MM; Baker D; Guinto J; Roth N; Ftouni S; Ognenovska K; Smith D; Hoy JF; Woolley I; Pell C; Templeton DJ; Fraser N; Rose N; Hutchinson J; Petoumenos K; Dawson SJ; Polizzotto MN; Dawson MA; Vincent T; Rosario R; Lau H; Smith D; Price S; O’Brien J; Tan HTL; Sinclair B; Bascombe F, 2021, 'HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults', Nature Medicine, 27, pp. 1006 - 1011, http://dx.doi.org/10.1038/s41591-021-01357-y

van Wyk J; Ait-Khaled M; Santos J; Scholten S; Wohlfeiler M; Ajana F; Jones B; Nascimento MC; Tenorio AR; Smith DE; Wright J; Wynne B, 2021, 'Improvement in Metabolic Health Parameters at Week 48 after Switching from a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/ Lamivudine: The TANGO Study', Journal of Acquired Immune Deficiency Syndromes, 87, pp. 794 - 800, http://dx.doi.org/10.1097/QAI.0000000000002655

Smith DE; Woolley IJ; Russell DB; Bisshop F; Furner V, 2020, 'Trends in practice: attitudes and challenges in the diagnosis, treatment and management of HIV infection in Australia', Internal Medicine Journal, 50, pp. 5 - 17, http://dx.doi.org/10.1111/imj.15129

Bloch M; John M; Smith D; Rasmussen TA; Wright E, 2020, 'Managing HIV-associated inflammation and ageing in the era of modern ART', HIV Medicine, 21, pp. 2 - 16, http://dx.doi.org/10.1111/hiv.12952

Harjanto R; Smith DE; Barratt H; Kelly M; Chan D; Furner V; Smith M; Ronnachit A; Post J; Rawlinson W, 2020, 'Utility of rapid plasmin reagin titres in assessing treatment response and re-infection for infectious syphilis', Sexual Health, 17, pp. 330 - 336, http://dx.doi.org/10.1071/SH20043

Bulsara SM; Begley K; Smith DE; Chan DJ; Furner V; Coote KV; Hennessy RM; Alperstein DM; Price A; Smith M; Wyson A; Wand H, 2019, 'The development of an HIV-specific complexity rating scale', International Journal of STD and AIDS, 30, pp. 1265 - 1274, http://dx.doi.org/10.1177/0956462419868359

Pearce E; Chan DJ; Smith DE, 2019, 'Empiric antimicrobial treatment for asymptomatic sexual contacts of sexually transmitted infection in the era of antimicrobial resistance: time to rethink?', International Journal of STD and AIDS, 30, pp. 137 - 139, http://dx.doi.org/10.1177/0956462418799181

Gatell JM; Morales-Ramirez JO; Hagins DP; Thompson M; Arasteh K; Hoffmann C; Raffi F; Osiyem O; Dretler R; Harvey C; Xu X; Plettenberg A; Smith DE; Portilla J; Rugina S; Kumar S; Frobose C; Wan H; Rodgers A; Hwang C; Teppler H, 2019, 'Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase lib trial', Antiviral Therapy, 24, pp. 425 - 435, http://dx.doi.org/10.3851/IMP3323

Keen P; Jamil M; Callander D; Conway DP; Mcnulty A; Davies SC; Couldwell DC; Smith DE; Holt M; Vaccher SJ; Gray J; Cunningham P; Prestage G; Guy R, 2019, 'Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before-after study (vol 16, pg 172, 2019)', SEXUAL HEALTH, 16, pp. 299 - 299, http://dx.doi.org/10.1071/SH18161_CO

Keen P; Jamil M; Callander D; Conway DP; McNulty A; Davies SC; Couldwell DC; Smith DE; Holt M; Vaccher SJ; Gray J; Cunningham P; Prestage G; Guy R; Read P; Varma R; O'Connor C, 2019, 'Rapid HIV testing increases testing frequency among gay and bisexual men: a controlled before–after study', Sexual Health, 16, pp. 172 - 179, http://dx.doi.org/10.1071/sh18161

Smith DE; Tom M; Bowden BH, 2018, 'Translation of clinical trial data to changes in clinical practice: rapid transition from tenofovir disoproxil fumarate to tenofovir alafenamide-based therapies in a Sydney HIV clinic', International Journal of STD and AIDS, 29, pp. 1011 - 1013, http://dx.doi.org/10.1177/0956462418761260

Smith DE; Woolley IJ; Russell DB; Bisshop F; Furner V, 2018, 'HIV in practice: current approaches and challenges in the diagnosis, treatment and management of HIV infection in Australia', HIV Medicine, 19, pp. 5 - 23, http://dx.doi.org/10.1111/hiv.12637

Chan DJ; Furner V; Smith DE; Dronavalli M; Bopage RI; Post JJ; Bhardwaj AK, 2018, 'Non-AIDS complexity amongst patients living with HIV in Sydney: Risk factors and health outcomes', AIDS Research and Therapy, 15, pp. 6, http://dx.doi.org/10.1186/s12981-018-0193-z

Stirrup OT; Copas AJ; Phillips AN; Gill MJ; Geskus RB; Touloumi G; Young J; Bucher HC; Babiker AG; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Lutsar I; Chêne G; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte A; Luca A; Prins M; Geskus R; Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AM; Rosinska M; Muga R; Tor J; Olalla P; Cayla J; Moreno S; Monge S; Amo J; Romero J; Pérez-Hoyos S; Sönnerborg A; Bucher C; Günthard H; Scherrer A; Malyuta R; Murphy G; Porter K; Johnson A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Price MA; Gilmour J; Kamali A; Karita E, 2018, 'Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion', HIV Medicine, 19, pp. 184 - 194, http://dx.doi.org/10.1111/hiv.12567

Siefried KJ; Mao L; Cysique LA; Rule J; Giles ML; Smith DE; McMahon J; Read TR; Ooi C; Tee BK; Bloch M; De Wit J; Carr A, 2018, 'Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy', AIDS, 32, pp. 35 - 48, http://dx.doi.org/10.1097/QAD.0000000000001685

Gray RT; Watson J; Cogle AJ; Smith DE; Hoy JF; Bastian LA; Finlayson R; Drummond FM; Whittaker B; Law MG; Petoumenos K; Han A, 2018, 'Funding antiretroviral treatment for HIV-positive temporary residents in Australia prevents transmission and is inexpensive', Sexual Health, 15, pp. 13 - 19, http://dx.doi.org/10.1071/SH16237

Cahn P; Kaplan R; Sax PE; Squires K; Molina JM; Avihingsanon A; Ratanasuwan W; Rojas E; Rassool M; Bloch M; Vandekerckhove L; Ruane P; Yazdanpanah Y; Katlama C; Xu X; Rodgers A; East L; Wenning L; Rawlins S; Homony B; Sklar P; Nguyen BY; Leavitt R; Teppler H; Cahn PE; Cassetti I; Losso M; Bloch MT; Roth N; McMahon J; Moore RJ; Smith D; Clumeck N; Vanderkerckhove L; Vandercam B; Moutschen M; Baril J; Conway B; Smaill F; Smith GHR; Rachlis A; Walmsley SL; Perez C; Wolff M; Lasso MF; Chahin CE; Velez JD; Sussmann O; Reynes J; Ferret S; Durant J; Duvivier C; Poizot-Martin I; Ajana F; Rockstroh JK; Faetkanheuer G; Esser S; Jaeger H; Degen O; Bickel M; Bogner J; Arasteh K; Hartl H; Stoehr A; Rojas EM; Arathoon E; Gonzalez LD; Mejia CR; Shahar E; Turner D; Levy I; Sthoeger Z; Elinav H; Gori A; Monforte ADA; Di Perri G; Lazzarin A; Rizzardini G; Antinori A; Celesia BM; Maggiolo F; Chow TS; Lee CKC; Azwa RISR; Mustafa M; Oyanguren M; Castillo RA; Hercilla L; Echiverri C; Maltez F; da Cunha JS; Neves I; Teofilo E; Serrao R; Nagimova F; Khaertynova I; Orlova-Morozova E; Voronin E; Sotnikov V; Yakovlev AA, 2017, 'Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial', The Lancet HIV, 4, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(17)30128-5

Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wasik TJ; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Chêne G; Dabis F; Thiebaut R; Masquelier B; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Kücherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte AD; De Luca A; Prins M; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Muga R; Tor J; de Olalla PG; Cayla J; del Amo J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Bucher HC; Rickenbach M; Francioli P; Malyuta R; Murphy G; Sabin C; Porter K; Johnson A; Phillips A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Gibb D; Grarup J; Kirk O; Kjaer J; Panteleev A; Reiss P; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; De Wolf F; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Anne AV, 2017, 'HIV-1 infection in persons homozygous for CCR5-Δ32 allele: The next case and the review', AIDS Reviews, 19, pp. 219 - 230

Puhr R; Petoumenos K; Youds D; Law MG; Templeton DJ; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Smith D; Rankin A; Baker D; O'Connor CC; Thackeray O; Jackson E; McCallum K; Ryder N; Sweeney G; Cooper D; Carr A; Macrae K; Hesse K; Finlayson R; Gupta S; Langton-Lockton J; Shakeshaft J; Brown K; Idle S; Arvela N; Varma R; Lu H; Couldwell D; Eswarappa S; Smith DE; Furner V; Cabrera G; Fernando S; Cogle A; Lawrence C; Mulhall B; Boyd M; Law M; Huang R; Han A; Gunathilake M; Payne R; O'Sullivan M; Croydon A; Russell D; Cashman C; Roberts C; Sowden D; Taing K; Marshall P; Orth D; Rowling D; Latch N; Warzywoda E; Dickson B; Donohue W; Moore R; Edwards S; Boyd S; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Woolley I; Giles M; Korman T; Williams J; Nolan D; Allen A; Guelfi G; Mills G; Wharry C; Raymond N; Bargh K, 2017, 'The impact of changes in HIV management guidelines on time to treatment initiation in Australia', HIV Medicine, 18, pp. 701 - 703, http://dx.doi.org/10.1111/hiv.12504

Smith DE; Gardiner J; Oliver R; Fagan D, 2017, 'Overlapping HIV prevention strategies; Case report of pre-exposure and postexposure prophylaxes used for a single risk event between two men', Sexually Transmitted Infections, 93, pp. 238 - 239, http://dx.doi.org/10.1136/sextrans-2014-051989

Keen P; Conway DP; Cunningham P; McNulty A; Couldwell DL; Davies SC; Smith DE; Gray J; Holt M; O'Connor CC; Read P; Callander D; Prestage G; Guy R, 2017, 'Multi-centre field evaluation of the performance of the Trinity Biotech Uni-Gold HIV 1/2 rapid test as a first-line screening assay for gay and bisexual men compared with 4th generation laboratory immunoassays', Journal of Clinical Virology, 86, pp. 46 - 51, http://dx.doi.org/10.1016/j.jcv.2016.11.006

De La Mata NL; Cooper DA; Russell D; Smith D; Woolley I; Sullivan MO; Wright S; Law M, 2016, 'Treatment durability and virological response in treatment-experienced HIV-positive patients on an integrase inhibitor-based regimen: An Australian cohort study', Sexual Health, 13, pp. 335 - 344, http://dx.doi.org/10.1071/SH15210

Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J; Chene G; Sabin C; Walker S; Fisher M; Kelleher T; Cooper D; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Dabis F; Thiebaut R; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Hamouda O; Kucherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Katsarou O; Rezza G; Dorrucci M; Monforte ADA; De Luca A; Prins M; Geskus R; Van Der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Rosinska M; Muga R; Tor J; De Olalla PG; Cayla J; Moreno S; Monge S; Del Romero J; Perez-Hoyos S; Sonnerborg A; Bucher HC; Gunthard H; Rickenbach M; Malyuta R; Murphy G; Johnson A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Grarup J; Kirk O; Bailey H; Anne AV; Panteleev A; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Sandhu M; Dedes N, 2015, 'Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?', AIDS, 29, pp. 2323 - 2333, http://dx.doi.org/10.1097/QAD.0000000000000805

Conway DP; Holt M; Couldwell DL; Smith DE; Davies SC; McNulty A; Keen P; Cunningham P; Guy R; Lockwood T; Wright S; Biggs K; Townsend J; Price A; Smith M; Koh A; Florance M; Leeman C; McNally L; Wilson K; Best S; Vincini J; Land S; Rawlinson W; Robertson P; Fennell M; O'Sullivan M; Kapitanos I; Dickeson D; Fernando S; Fulton R, 2015, 'Barriers to HIV testing and characteristics associated with never testing among gay and bisexual men attending sexual health clinics in Sydney', Journal of the International AIDS Society, 18, pp. 20221, http://dx.doi.org/10.7448/IAS.18.1.20221

De La Mata N; Mao L; De Wit J; Smith D; Holt M; Prestage G; Wilson DP; Petoumenos K, 2015, 'Estimating antiretroviral treatment coverage rates and viral suppression rates for homosexual men in Australia', Sexual Health, 12, pp. 453 - 457, http://dx.doi.org/10.1071/SH15037

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Nwizu C; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Avihingsanon A; Boyd M; Carey D; Clarke A; Courtney-Vega K; Delfino M; Donaldson A; Emery S; Espinosa N; Johannesen T; Lin E; Losso M; Moricz A; Pett S; Phanupak P; Puls R; Pussadee K; Sutheerasak P; Tomlins L; Ubolyam S; bin Raja Azwa RIS; Bissio E; Calanni L; Chetchotisakd P; Doong N; Elliott J; Gazzard B; Kelly M; Laplume H; del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Phanuphak P; Rockstroh J; Rowling D; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Dunn D; Dolan M; Emery S; Kelleher A, 2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', The Lancet Infectious Diseases, 15, pp. 793 - 802, http://dx.doi.org/10.1016/S1473-3099(15)70060-5

Conway DP; Guy R; Mcnulty A; Couldwell DL; Davies SC; Smith DE; Keen P; Cunningham P; Holt M; Lockwood T; Wright S; Biggs K; Townsend J; Price A; Smith M; Koh A; Florance M; Rawlinson WR; Robertson P; Fennell M; O'Sullivan WM; Kapitanos I; Dickeson D; St Leonards A; Fernando S; Fulton R; McNally L; Wilson K; Best S; Vincini J; Land S, 2015, 'Effect of testing experience and profession on provider acceptability of rapid HIV testing after implementation in public sexual health clinics in Sydney', HIV Medicine, 16, pp. 280 - 287, http://dx.doi.org/10.1111/hiv.12209

Conway DP; Guy R; Davies SC; Couldwell DL; McNulty A; Smith DE; Keen P; Cunningham P; Holt M; Lockwood T; Wright S; Biggs K; Townsend J; Price A; Smith M; Koh A; Florance M; Rawlinson W; Robertson P; Fennell M; O'Sullivan M; Kapitanos I; Dickeson D; Fernando S; Fulton R; Leeman C; McNally L; Wilson K; Best S; Vincini J; Land S, 2015, 'Rapid HIV testing is highly acceptable and preferred among high-risk gay and bisexual men after implementation in Sydney sexual health clinics', PLoS ONE, 10, pp. e0123814, http://dx.doi.org/10.1371/journal.pone.0123814

Wright ST; Law MG; Cooper DA; Keen P; McDonald A; Middleton M; Woolley I; Kelly M; Petoumenos K; Ellis D; Bloch M; Agrawal S; Vincent T; Allen D; Little JL; Smith D; Mincham C; Baker D; Ieroklis V; Templeton DJ; O'Connor CC; Phan S; Jackson E; McCallum K; Grotowski M; Taylor S; Carr A; Lee F; Hesse K; Sinn K; Norris R; Finlayson R; Prone I; Patel A; Varma R; Shakeshaft J; Brown K; McGrath V; Halligan S; Wray L; Read P; Lu H; Couldwell D; Furner V; Fernando S; Chuah J; Watson J; Lawrence C; Mulhall B; McManus H; Bendall C; Boyd M; Ryder N; Payne R; Russell D; Doyle-Adams S; Sowden D; Taing K; McGill K; Orth D; Youds D; Gibson A; Magon H; Dickson B; Donohue W; Moore R; Edwards S; Liddle R; Locke P; Roth NJ; Lau H; Read T; Silvers J; Zeng W; Hoy J; Watson K; Bryant M; Price S; Giles M; Hoy J; Williams J; Nolan D; Robinson J; Morwood K; Roth N; Choong K; Li PCK; Lee MP; Vanar S; Faridah S; Kamarulzaman A; Choi JY; Vannary B; Ditangco R; Tsukada K; Pujari S; Makane A; Ng OT; Sasisopin AJ; Han A, 2015, 'Temporal trends of time to antiretroviral treatment initiation, interruption and modification: Examination of patients diagnosed with advanced HIV in Australia', Journal of the International AIDS Society, 18, pp. 19463, http://dx.doi.org/10.7448/IAS.18.1.19463

Petoumenos K; Watson J; Whittaker B; Hoy J; Smith D; Bastian L; Finlayson R; Sloane A; Wright ST; McManus H; Law MG; Han A, 2015, 'Subsidized optimal ART for HIV-positive temporary residents of Australia improves virological outcomes: Results from the Australian HIV Observational Database Temporary Residents Access Study', Journal of the International AIDS Society, 18, pp. 19392, http://dx.doi.org/10.7448/IAS.18.1.19392

Armstrong B; Chan DJ; Stewart MJ; Fagan D; Smith D, 2015, 'Single Tablet Regimen Usage and Efficacy in the Treatment of HIV Infection in Australia', AIDS Research and Treatment, 2015, http://dx.doi.org/10.1155/2015/570316

Conway DP; Holt M; McNulty A; Couldwell DL; Smith DE, 2014, 'Correction: Multi-centre evaluation of the determine HIV combo assay when used for point of care testing in a high risk clinic-based population (PLoS ONE (2014) 9, 4 (e94062) DOI: 10.1371/journal.pone.0094062)', PLoS ONE, 9, http://dx.doi.org/10.1371/journal.pone.0103399

Wright ST; Hoy J; Mulhall B; OʼConnor CC; Petoumenos K; Read T; Smith D; Woolley I; Boyd MA; O'Connor C, 2014, 'Determinants of Viremia Copy-Years in People With HIV/AIDS After Initiation of Antiretroviral Therapy', JAIDS Journal of Acquired Immune Deficiency Syndromes, 66, pp. 55 - 64, http://dx.doi.org/10.1097/qai.0000000000000125

Conway D; Holt M; McNulty A; Couldwell D; Smith D; Davies S; Cunningham P; Keen P; Guy R, 2014, 'Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population', PLoS One, 9, pp. e94062-1 - e94062-8, http://dx.doi.org/10.1371/journal.pone.0094062

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Emery S; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Losso M; Nwizu C; Phanuphak P; Ripin D; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Boyd M; Carey D; Clarke A; Courtney-Vega K; Dazo C; Delfino M; Donaldson A; Espinosa N; Johannesen T; Kaew-On P; Lin E; Moricz A; Taylor J; Phanupak P; Puls RL; Pussadee K; Sutheerasak P; Tomkins L; Ubolyam S; Shah Bin Raja Azwa RI; Bissio E; Calanni L; Casiro A; Chetchotisakd P; Contarelli J; Doong N; Elliott J; Gazzard B; Kelly M; Del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Pett S; Rockstroh J; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Crabtree-Ramiraz B; Winston E; Dunn D; Dolan M; Cooper D; Kelleher A, 2014, 'Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial', The Lancet, 383, pp. 1474 - 1482, http://dx.doi.org/10.1016/S0140-6736(13)62187-X

Rafiee M; Kariminia A; Wright S; Mills G; Woolley I; Smith D; Templeton DJ; Law MG; Petoumenos K, 2014, 'Reducing Viral Load Measurements to Once a Year in Patients on Stable, Virologically Suppressive Cart Regimen: Findings from the Australian HIV Observational Database', Journal of AIDS & Clinical Research, 5, pp. 383, http://dx.doi.org/10.4172/2155-6113.1000383

Bourne C; Allen D; Brown K; Davies SC; McNulty A; Smith DE; O'Connor CC; Couldwell D; Jackson E; Bolton M; Rodgers C; Konecny P; Smith DJ; Parker A, 2013, 'Erratum: What proportion of sexually transmissible infections and HIV are diagnosed in New South Wales public sexual health services compared with other services?', Sexual Health, 10, pp. 290, http://dx.doi.org/10.1071/sh12020_co

Bourne C; Allen D; Brown K; Davies SC; McNulty A; Smith DE; O'Connor CC; Couldwell D; Jackson E; Bolton M; Rodgers C; Konecny P; Smith DJ; Parker A, 2013, 'What proportion of sexually transmissible infections and HIV are diagnosed in New South Wales public sexual health services compared with other services? (vol 10, pg 119, 2013)', SEXUAL HEALTH, 10, pp. 290 - +, http://dx.doi.org/10.1071/SH12020_CO

Bourne C; Allen D; Brown K; Davies SC; McNulty A; Smith DE; O'Connor CC; Couldwell D; Jackson E; Bolton M; Rodgers C; Konecny P; Smith DJ; Parker A, 2013, 'What proportion of sexually transmissible infections and HIV are diagnosed in New South Wales? public sexual health services compared with other services?', Sexual Health, 10, pp. 119 - 119, http://dx.doi.org/10.1071/SH12020

Post JJ; Khor C; Furner VL; Smith DE; Whybin LR; Robertson PW, 2012, 'Case report and evaluation of the frequency of the prozone phenomenon in syphilis serology an infrequent but important laboratory phenomenon', Sexual Health, 9, pp. 488 - 490, http://dx.doi.org/10.1071/SH11156

Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377

Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T, 2012, 'Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere', HIV Medicine, 13, pp. 352 - 357, http://dx.doi.org/10.1111/j.1468-1293.2011.00987.x

Sasson SC; Zaunders J; Seddiki N; Mcbride K; Koelsch KK; Merlin KM; Smith DE; Cooper DA; Kelleher AD; Bailey MR, 2012, 'Progressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infection', PLoS One, 7, pp. e31148, http://dx.doi.org/10.1371/journal.pone.0031148

Back to profile page